Visugromab

Approval Year

Name

Type

Language

CTL-002

Preferred Name

English

Visugromab

Official Name

English

CTL002

Code

English

VISUGROMAB [USAN]

Common Name

English

gamma4 heavy chain (1-444) [VH (Homo sapiens IGHV2-5*02 (92.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [10.7.10] (26-35.53-59.98-107)) (1-118)-Homo sapiens IGHG4*01, G4v5 h P10 (CH1 (119-216), hinge 1-12 S10>P (226) (217-228), CH2 (229-338), CH3 (339-443), C

Common Name

English

immunoglobulin G4-kappa, anti-[Homo sapiens GDF15 (growth differentiation factor 15, PLAB, MIC-1, PDF, MIC1, NAG-1, PTGFB)], monoclonal antibody

Common Name

English

Visugromab [WHO-DD]

Common Name

English

visugromab [INN]

Common Name

English

Immunoglobulin G4 [226-proline,de-445-lysine], anti-(human growth differentiation factor 15) (human-Mus musculus monoclonal CTL-002 ?4-chain), disulfide with human-Mus musculus monoclonal CTL-002 ?-chain, dimer

Systematic Name

English

Code System Code Type Description

SMS_ID

300000022231